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SOMMARIO 
Introduzione. Nel presente lavoro sono stati valutati una serie di campioni di 
midollo osseo provenienti da autopsie giudiziarie allo scopo di valutare le 
modificazioni morfologiche post-mortali e l’eventuale possibilità di utilizzare 
l’analisi immunofenotipica per scopi medico-legali.  
Materiali e metodi. Sono stati esaminati 36 campioni di sterno prelevati in sede 
autoptica: 11 campioni sono stati presi da soggetti morti per sospetto annegamento 
nel periodo 2015-2017. Dopo il prelievo i campioni erano posti in contenitori di 
plastica e conservati refrigerati a (-20 C°) senza ulteriori trattamenti. Dieci 
campioni erano prelevati da soggetti morti per cause diverse; tali campioni erano 
fissati in formalina per un tempo variabile. 15 campioni erano prelevati da autopsie 
non giudiziarie. Su tutti i campioni era eseguita colorazione ematossilina-eosina 
dopo decalcificazione- fissazione. I dettagli morfologici erano valutati da tre 
differenti patologi. Parte di ciascun singolo sterno veniva decalcificata e fissati per 
tempi diversi in un range di giorni. Per la decalcificazione era utilizzato il 
decalcificatore in grado di decalcificare e fissare allo stesso tempo. Su tutti i 
campioni è stata eseguita l’analisi immunoistochimica utilizzando i seguenti 
anticorpi commerciali: CD20, CD3, CD71, CD61, mielo-perossidasi e CD34 di cui 
sono commercialmente disponibile i cloni. L’analisi dei preparati è stata eseguita 
utilizzando sia il microscopio Olympus BX51 sia il Fluo-scan-scope dopo 
digitalizzazione dei vetrini (e-slide). 
Risultati. I campioni di midollo osseo sono risultati interpretabili 
morfologicamente in 21 dei 36 casi studiati (58%) e completamente interpretabili 
(dopo la valutazione morfologica e immunofenotipica) in 22 dei 36 casi esaminati 
(61%). Nello specifico i risultati sono stati interpretabili in 1/11 (9%) dei campioni 
congelati, in 8/10 (80%) dei casi giudiziari e in 13/15 (87%) dei casi non giudiziari. 
La presenza di cellule ematopoietiche tri-lineari (cellule mielo-eritroidi e 
megacariociti) era identificata sia a livello morfologico che immunofenotipico in 
tutti i gruppi ad eccezione della serie congelata dove si osservava tessuto 
degenerativo apoptotico. In uno solo dei campioni congelati il dato risultato 
risultava interpretabile; i caratteri di cellularità immunofenotipici così come la 
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distinzione della componente eritroide e mieloide era mantenuta. Il resto dei 
campioni congelati permetteva la visualizzazione della cellularità del midollo osseo 
senza distinzione delle singole componenti. 
7 dei 10 campioni dei casi giudiziari risultavano interpretabili da un puto di vista 
istopatologico. La cellularità e le componenti cellulari (distinzione tra linea mielo-
eritroide e megacariociti) era possibile mediante immunoistochimica in 8 dei 10 
casi. L’analisi immunofenotipica poteva essere ben interpretata solo dopo 
decalcificazione lenta e fissazione in un range di 8-14 giorni. 
I campion congelati non risultavano adeguati per la valutazione istopatologica e per 
la successiva analisi immunofenotipica a causa della diffusa assenza di tessuto 
idoneo. 
L’anticorpo CD71 era valutabili come dots nei campioni congelati senza dettagli 
morfologici ed era valutabile come percentuali di cellule; lo stesso anticorpo nei 
casi non giudiziari e nei campioni giudiziari era facilmente contabile. Gli anticorpi 
CD3, CD20 e CD34 non mostravano alcuna positività nello sterno congelato mentre 
nei rimanenti campioni mostravano una immuno-espressione appropriata rispetto 
alle cellule specifiche (cellule immature linfoidi della serie T e B). 
Conclusioni. L’analisi dei dati sperimentali ha evidenziato 3 punti principali: 1. il 
processo slow day-by-day slow decalcifying usualmente permette di ottenere un 
campione di midollo osseo dalle autopsie giudiziarie morfologicamente 
interpretabile; 2. l’analisi immunofenotipica può essere eseguita sul tessuto solo 
dopo decalcificazione lenta, usualmente dopo 8-14 giorni; 3. campioni congelati 
non sono idonei per l’analisi isto-patologica. 
Tali dati portano a formulare la seguente valutazione conclusiva rispetto all’uso del 
midollo osseo in ambito forense. Il prelievo di sterno al fine di ottenere midollo 
osseo non è mandatorio in tutte le autopsie giudiziarie ma risulta raccomandabile 
nei casi di sospetta malattia ematologica, nei casi morte improvvisa, nei casi di 
morte su base settica. In questi casi si dovrebbe procedere al prelievo di una sezione 
di sterno di 2x3 cm; il campione dovrebbe essere sottoposto a fissazione e lenta 
decalcificazione per un tempo ottimale di 8-14 giorni. Mediante tale procedura si 
ottengono sezioni di midollo osseo morfologicamente interpretabili su cui è 
possibile eseguire analisi immunofenotipiche.  
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ABSTRACT 
Background. We sought to investigate a series of bone marrow specimens from 
forensic autopsies, with focus on post-mortem morphological changes and utility 
of the immunophenotypical analysis for medical-legal purposes.  
Materials and Methods. Thirty-six samples of the sternum taken during autopsies 
were examined: 11 samples were taken from subjects who died due to suspected 
drowning, in the period 2015-2017; the samples were placed inside a plastic con-
tainer and stored in the freezer (-20C°) without being subjected to further treat-
ments. 10 samples were taken from subjects who died due to several causes; the 
samples were fixed in formalin for a variable time; 15 samples were taken from 
non-forensic autopsies. 
H&E staining has been performed on all samples after decalcification&fixation.  
Morphological details has been categorized by three pathologists. Part of single 
sternum has been decalcified and fixed at different time (range in days). Decalcifier 
I is a unique decalcifying solution that has the ability to fix and decalcify at the 
same time.  
Immunohistochemistry has been performed on all cases after inclusion of the fol-
lowing commercially available antibodies: CD20, CD3, CD71, CD61, myeloperox-
idase and CD34 (commercially available clones). Data analysis has been performed 
by using both the Olympus BX51 microscope and D-Sight/Menarini Fluo-scan-
scope, after digitalization of the glass slides (e-slide). 
Results. Overall, bone marrow samples were morphologically interpretable in 
21/36 (58%) cases, were fully (after morphological and immunophenotypical data) 
interpretable in 22/36 (61%) cases, respectively 1/11 (9%) in the frozen samples, in 
8/10 (80%) in the prospective day-by-day slow decalcified series and in 13/15 
(87%) non-forensic series. 
All trilinear haematopoietic cells (myelo-erythroid cells and megakaryocytes) were 
detailed at both morphology and immunophenotypical levels in all groups expect 
in the frozen series, where the apoptotic degenerative tissue was observed. In the 
single cases (1/11%, 9%) of samples taken at frozen temperature resulted interpret-
able; cellularity and immunophenotypical characters such as distinction in between 
myeloid and erythroid components were maintained. The rest of the frozen series 
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(9 cases out of 11, 91%) allowed visualization of the overall bone marrow cellular-
ity, without distinction of the single components. In the prospective day-by-day de-
calcified series 7/10 (70%) of cases were interpretable for histopathology. Cellular-
ity and detailed cellular components (mielo-erythroid distinction and megakaryo-
cytes) by using immunohistochemistry were distincted in 8/10 (80%). Immunophe-
notypical analysis may be well interpreted on tissue after slow decalcification and 
fixation within a 8-14 range days. Frozen samples are not recommended for histo-
pathological evaluation and subsequent immunophenotypical analysis, due to dif-
fuse absence of suitable tissue.  
CD71 was assessable as dots at frozen samples, without morphological details, and 
be evaluable as percentages of cells. CD71 in non-forensic and prospective cases 
was easily countable. 
CD3, CD20 and CD34 did not show any positivity in the frozen sternum, whereas 
in the remaining series showed immunoexpression according to appropriate specific 
cells (T and B lymphoid and immature cells). 
Conclusions. We found that: 1. slow day-by-day decalcifying process usually let 
the bone marrow from sternum after forensic autopsies, be morphologically inter-
pretable; 2. immunophenotypical analysis may be performed on tissue after slow 
decalcification and fixation usually within 8-14 days; 3. frozen samples are not rec-
ommended for histopathological evaluation. 
The above reported considerations lead to the following final conclusion. The 
sternum collection in forensic autopsies in order to evaluate the bone marrow is not 
mandatory in all the forensics cases. However it is recommended in all the cases of 
suspected haematological diseases, sudden deaths and septic deaths. In these cases 
the forensic pathologist must collect a section of the sternum 2x3 cm, which must 
be subjected to slow decalcification and fixation within 8-14 days. Following this 
procedure it is possible to obtain interpretable bone marrow preparations suitable 
also for the immunophenotypical analysis. 
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INTRODUCTION 
Bone marrow samples is still not a routine procedure in the context of forensic 
autopsies, due to few data available.  
We sought to investigate a series of sternum obtained from autopsies (forensic and 
non-forensics), to evaluate sensibility and specificity of detailed morphology and 
immunophenotyical findings in forensic cases. 
1. BONE MARROW 
1.1 ANATOMY AND PHYSIOLOGY 
In the human embryo during the third week of development, groups of stem cells 
appear; some of these cells in the third month of embryogenesis migrate into the 
liver. This organ is the main site of blood cell formation until just before birth. 
Starting from the fourth month of gestation, the hematopoiesis begins also in the 
bone marrow. At birth, the bone marrow of the whole skeletal system is involved in 
the hematopoiesis until puberty. 
From the age of 18 the hematopoietic bone marrow (red) is present only in the 
vertebrae, in the ribs, in the sternum, in the skull, in the pelvic bones, and in the 
proximal epiphyseal regions of the humerus and femur [Kuma V. et al., 2014] 
[figure 1]. 
 
Figure 1: amount of red bone marrow-age of the subject. 
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The bone marrow is found within the central cavities of axial and long bones. The 
bone marrow has three components: hematopoietic cells, 
stroma/microenvironment, and medullary bone. It consists of hematopoietic tissue 
islands and adipose cells surrounded by vascular sinuses interspersed within a 
meshwork of trabecular bone. The bone marrow is the major hematopoietic organ 
and a primary lymphoid tissue, responsible for the production of erythrocytes, 
granulocytes, monocytes, lymphocytes and platelets. The inner surface of the bone 
cavities and the outer surface of the cancellous bone spicules within the cavities are 
covered by an endosteal lining consisting of a single layer of flat “bone-lining cells” 
supported by a thin layer of reticular connective tissue; osteoblasts and osteoclasts 
are also found within the endosteal lining. In long bones, one or more nutrient canals 
(containing a nutrient artery and 1 or 2 nutrient veins) pass through the cortical bone 
entering the marrow cavity obliquely. In flat bones, the marrow is served by 
numerous blood vessels of various sizes entering the marrow via large and small 
nutrient canals [figure 2, 3].  
 
Figure 2: bone marrow structure. 
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Figure 3: bone marrow structure. 
 
After entry, the artery splits into ascending and descending branches that run 
parallel to the long axis in the central part of the marrow cavity, coiling around the 
primary venous marrow channel, the central longitudinal vein. These artery 
branches give rise to a multitude of small thin-walled arterioles and capillaries that 
extend outwardly toward the cortical bone. Near the bone, the arterioles open up 
and anastomose with a plexus of venous sinuses. These venous sinuses drain via 
collecting venules that lead back centrally to the central longitudinal vein that then 
drains via the nutrient veins. The marrow has an extensive blood supply. Also, it 
appears that nutrient artery-derived capillaries extend into the Haversian canals, 
return to the marrow cavity then open into the venous sinuses. Thus, there is a 
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circular pattern to blood flow within the marrow cavity, from the center of the 
marrow cavity toward the periphery of the marrow cavity then back toward the 
center. In long and flat bones, the blood supplies of the bone and bone marrow are 
interconnected through an endosteal network of vessels. The venous sinuses are 
thin-walled, consisting of a layer of flat endothelial cells with little to no basement 
membrane. The marrow does not have lymphatic drainage. The hematopoietic 
tissue consists of a variety of cell types including, the blood cells and their 
precursors, adventitial/barrier cells, adipocytes, and macrophages. The 
hematopoietic tissue cells are not randomly arranged but demonstrate a particular 
organization within the tissue [Travlos GS et al, 2006; Weiss L. et al, 1991][Figure 
4]. 
 
 
Figure 4: histology of the bone marrow. 
 
For hematopoiesis to occur it must be supported by a microenvironment that is able 
to recognize and retain hematopoietic stem cells and provide the factors (e.g., 
cytokines) required to support proliferation, differentiation and maturation of stem 
cells along committed lineages.  
The functional unit of hematopoiesis, the bone marrow microenvironment, includes 
the capillary-venus sinus, the surrounding extra-cellular matrix, and stromal cells 
(fibroblasts, macrophages, endothelial cells, adipocytes, and reticular cells). The 
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extracellular matrix includes regulatory factors as well as fibronectin, collagen, 
laminin, and various proteoglycans. Interactions with the bone marrow 
microenvironment determine the fate of hematopoietic stem cells, since all aspects 
of hematopoietic stem cell activity are influenced by bone marrow 
microenvironment niches [MaiKa M. et al, 2011; Foucar K. et al, 2008] 
Upon maturation, the hematopoietic cells, regulated by the barrier cells, traverse 
the wall of the venous sinuses to enter the bloodstream; platelets are released 
directly into the blood from cytoplasmic processes of megakaryocytes penetrating 
through the sinus wall into the sinus lumen.  
Some of humoral factors act on the more primitive cells and have a general action, 
while others act on later progenitors of a specific cell line.  Most interleukins, B-
cell growth factor, and B-cell differentiation factor are derived from T-lymphocytes. 
IL-1 is produced by macrophages. 
Hematopoiesis is a continuous process, but can be separated into distinct stages. 
The first stage involves uncommitted (pluripotent) stem cells contained in the bone 
marrow. These pluripotent cells have two primary functions. First, they maintain 
their numbers by a process of self renewal and, secondly, they have the ability to 
give rise to all hematopoietic cells (erythrocytes, granulocytes, lymphocytes, 
monocytes, and platelets) [Travlos GS. Et al, 2006][Figure 5]. 
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Figure 5: Representation of the maturation progression of the multiple cellular lineages 
present in the bone marrow. CFU = colony forming unit; E = erythyroid; Meg = 
megakaryocyte; Gemm = granulocytic, erythyroid, monocyte-macrophage, and 
megakaryocytic; GM = granulocyte/monocyte; G = granulocyte; M = monocyte; Eo = 
eosinophil; Baso = basophil; L = lymphocyte. Drawing by David Sabio. 
 
A representative estimate of bone marrow activity can be obtained by examining 
the relationship between adipose cells and haematopoietic cells in bone marrow 
biopsies. In normal conditions, this ratio is about one, but in the condition of 
medullary hypoplasia the proportion of the adipocytes increases. The fat cells 
instead can also disappear in the conditions of increased haematopoiesis. 
Normally, the bone marrow contains 60% of granulocytes and their precursors; 20% 
of erythroid precursors; 10% of lymphocytes and monocytes and their precursors 
and 10% of unidentified cells or in the process of destruction. As a result, the 
myeloid/erythroid ratio is 3: 1 [Orazi A. et al, 2007]. 
 
With the increase of the age of the subject or in particular pathological conditions 
the bone marrow can change its composition. Reactive marrow changes can be 
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quantitative (hyperplasia or hypoplasia) or qualitative (left-shifted maturation, 
cyologic atypia), and they can affect one or multiple hematopoietic lineages as well 
as the lymphoid, histiocytic, or stromal marrow compartments. Causes of reactive 
bone marrow changes typically originate outside of the marrow itself. The 
differential diagnosis includes autoimmune disease, nutritional deficiency or 
excess, toxic insults, medications, and infections [Tracy I. et al, 2018].  
 
Hormones also play a physiological role. Hormones of the pituitary, adrenals, 
thyroid and gonads appear to participate in erythropoiesis by altering erythropoietin 
production and erythroid progenitor response to other factors. For example, 
androgens, thyroxine and growth hormone increase erythropoietin production; 
estrogen has an inhibitory erythropoietic effect. Hematopoietic tissue is also 
sensitive to external influences and can become suppressed in response to dietary 
restriction, chronic inflammation, and proliferative or neoplastic disorders [Travlos 
GS. et al, 2006]. 
 
With aging there is a progressive and physiological reduction of the amount of 
hemato-poietic bone marrow (red marrow) and an increase in adipose cells (yellow 
marrow). In fact, the marrow cellularity is estimated by the percentage of hemato-
poietic cells in the total volume of marrow space; it declines with age, showing the 
highest cellularity in an infant or a young child and the lowest in an elderly person. 
Some examples are shown below. 
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Figure 6: biopsy of 4 year-old boy is shown; the bone marrow space is occupied by 
approximately 90% cellularity with hematopoietic cells and approximately 10% by 
adipose cells, which is normal cellularity for the age of 4 years [Tracy I. eta al, 2018]. 
 
 
Figure 7: biopsy of 42 year old woman is shown; the marrow space is occu-
pied by approximately 50-60% hematopoietic cells with trilineage hematopoi-
esis and approximately 40-50% adipose cells, which is normal cellularity for 
the age of 42 years [Tracy I. eta al, 2018]. 
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Figure 8: biopsy of 78 year old man is shown; the marrow space has signifi-
cantly reduced hematopoietic cells (approximately 20%), which are replaced 
by adipose cells (approximately 80%). The cellularity in this figure is normal 
for the age of 78 years [Tracy I. eta al, 2018]. 
 
1.2 DIAGNOSTIC ASPECTS 
In the clinical setting, the bone marrow examination is an important diagnostic 
procedure used for a wide variety of clinical conditions including the diagnosis of 
myeloid or lymphoid neoplasms, various reactive conditions or metastatic, non-
hematopoietic malignancies. Bone marrow examination is also used for 
confirmation or monitoring of a remission state, residual or recurrent disease state, 
or regeneration of bone marrow after various therapies.  
In any case, bone marrow analysis is a part of a multi-pronged evaluation of the 
hematopoietic system which includes also peripheral blood exam, complete blood 
count with differential, bone marrow smear exam and evaluation of cytocentrifuge 
preparations and/or bone marrow histopathology.  
Bone marrow aspiration and biopsy are considered to represent overall bone 
marrow function [Tracy I. eta al, 2018]. 
Bone marrow samples can be obtained by: 
- aspiration: a sample of the fluid part of the bone marrow containing the cells is 
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collected through the needle aspiration of the bone marrow so that they can be 
examined under a microscope. The sample is swiped on a slide and stained. The 
analysis evaluates the cell number, type, maturity, appearance, etc. [Figure 9]; 
 
 
Figure 9: aspiration of bone marrow on a slide. 
 
- osteomidullary biopsy: a sample of bone marrow tissue is taken, preserving the 
structure of the tissue. A larger caliber needle is inserted into the bone and the 
instrument is withdrawn into which a small cylindrical fragment of tissue remains. 
The fragment can be fixed in formalin, decalcified, paraffin-embedded, sectioned 
and stained. [figure 10]; 
 
 
Figure 10: osteomidullary biopsy 
 
Histopathology is a subjective assessment and is useful for evaluating bone marrow 
architecture, assessment of cellularity, estimation of M:E ratio (limited sensitivity), 
assessment of cell lineages, estimation of iron stores and other features (e.g., 
neoplasia, inflammation, pigment, infectious agents).  
In general, decalcified, paraffin-embedded, haematoxylin and eosin (H&E)-stained 
sections of bone marrow, the more mature stages of the erythroid and myeloid cells, 
adipocytes, mast cells, and megakaryocytes can be identified, but stem cells, 
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immature myeloid, erythroid, lymphoid, monocytoid and stromal cells cannot be 
identified consistently. An estimation of general hematopoietic activity and the 
myeloid/erythroid ratio can also be performed [Travlos GS et al, 2006].  
For histopathology, numerous variables regarding specimen collection and 
processing (e.g., fixation, decalcification, embedding, sectioning and staining) may 
affect the quality of the sample to be evaluated and must be considered. 
Fixation 
After the withdrawal, marrow should be collected as soon as possible for 
histological assessment. Fixative solutions stabilize tissue by cross-linking 
proteins; the degree of cross-linking may result in denaturation of proteins and 
affects morphological, cytochemical or immunohistochemical qualities of the 
specimen.  
Because its readily available, 10% neutral buffered formalin (10% NBF) is the most 
commonly used fixative. For routine H&E sections, no special handling is required 
prior to tissue processing. 10% NBF-fixed tissues may be used for frozen sections 
and evaluation of adipocytes. 
For specimens to be used for immunohistochemistry, a prolonged fixation in 10% 
NBF may be detrimental (e.g., loss of antigenic epitopes due to continued amino 
group crosslinking and alteration of tertiary protein structure). Transferring the 
tissue to 70% ethanol after a 12-hour fixation reduces fixation-related effects. 
Decalcification 
For paraffin-embedded sections, bone marrow specimens must be decalcified prior 
to sectioning; specimens for plastic embedding do not. There are numerous types 
of decalcifiers (e.g., acids, chelators, resins) and methods (e.g., immersion, 
sonication, microwave, ion-exchange) for the decalcification of bone marrow 
specimens. If preservation of enzyme reactivity or antigenic sites is required, 
selection of the method of decalcification is important. With larger specimens, some 
damage to tissue morphology, due to decalcification, is almost unavoidable 
(especially with the use of acid decalcifiers). 
Both organic and mineral acids are commonly used for decalcification of bone 
marrow specimens. Organic acids (e.g., formic and acetic) decalcify slower than 
mineral acids (e.g., HCL and nitric). Mineral acids are commonly used in the rapid-
type decalcification methods. Over decalcification of tissue with acids, particularly 
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mineral acids, results in tissue destruction. Thus, tissue in acid decalcifiers should 
not be left unchecked for extended periods (e.g., over a weekend). For proper 
decalcification, there must be even distribution of acid around bone sample. Thus, 
tissue suspension or mild agitation, such as gentle mixing (e.g., shaker/rocker) or 
air bubble percolation, may be useful. Additionally, acid decalcifiers may need 
frequent solution changes (e.g., daily) for adequate decalcification. In general, acid 
decalcification is not recommended for samples needed for enzyme or 
immunostaining. This caveat is particularly appropriate for the mineral acids like 
HCL or nitric; the organic acids appear to be somewhat better. All acid decalcifiers, 
especially mineral acids, reduce morphological quality and Giemsa stains may be 
unacceptable due to loss of basophilic-staining structures [Travlos GS et al, 2006] 
In this regard Sung-Eun Choi et al, formulated a protocol that compared various 
decalcification methods (hydrochloric acid –HCl; ethylenediaminetetraacetic acid 
disodium salt dehydrate -EDTA; RDO-GOLD RDO), concluding that the EDTA 
protocol would be the best to preserve the genetic material. RDO can be an 
acceptable alternative when rapid decalcification is required [Sung EC. Et al, 2015]. 
Other authors suggest that decalcification is best achieved by 14% EDTA that 
sequesters metallic ions, including calcium, in aqueous solutions as a chelating 
factor for 16–24 h [Torlakovic EE. Et al, 2015] 
However, new decalcifying solutions are being developed, and some may be less 
deleterious to bone marrow tissue even after short fixation. After fixation and 
decalcification, the tissue needs to be further processed before embedding in 
paraffin [Peterson LC. et al, 2001] 
The most important problem is inadequate tissue dehydration and clearing prior to 
paraffin embedding. This can be prevented by preparing all solutions freshly every 
week, depending on the volume of tissue processed [Werner M. et al, 2000]. 
Embedding  
The preparation of bone marrow sections in a laboratory of routine histology 
requires, after decalcification, the inclusion in paraffin. This technique has the 
disadvantage of producing a narrowing and a considerable loss of cellular detail. In 
the mid-1980s a new inclusion technique was evaluated using plastic inclusion. This 
work [Islam A, Frisch B.-1985] describes a simplified routine procedure for the use 
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of methyl methacrylate as a plastic embedding medium for the preparation of semi-
thin sections of non-calcified bone marrow. The study also proposed a modification 
of the May-Grunwald-Giemsa stain that provides good color differentiation of 
various hematopoietic cells in the bone marrow. The authors concluded that the 
method was simple, reproducible, did not require expensive equipment and was 
suitable for routine processing of bone marrow biopsy nuclei in any histopathology 
laboratory [Islam A. et al, 1985]. 
However, other authors suggested that under optimal circumstances, morphology 
looks superior in plastic-embedded tissue. However, there is experiential evidence 
of excellent morphology with appropriate fixation time and thin sectioning (2 um) 
of tissue for formalin, AZF fixatives, and the need for embedding in plastic was 
challenged in 1987 by Gatter et al. Plastic embedding techniques may obviate the 
need for the decalcification step and thus eliminate one of the major variables 
impacting pre-analytical bone marrow IHC quality. However, only a few centres 
still cultivate expertise required for plastic embedding. Without a resurgence of 
interest and developmental efforts leading to broader use of plastic embedding, 
paraffin embedding will remain the method of choice in the great majority of 
laboratories. If plastic embedding could be automated and cost-effective, it could 
become a preferred choice for embedding of all types of tissue biopsies, not only 
bone marrow samples [Peterson G. et al, 2001]. 
For example Krenacs T et al, suggested the processing of bone marrow biopsies by 
buffered fixation of formaldehyde and inclusion of epoxy, with or without 
decalcification of EDTA. The technique can be considered as a period of time 
similar to that of paraffin processing with only a cost increase of about 30%, 
offering an alternative possibility to paraffin processing for diagnosis and research 
[Roll P. et al, 2009]. 
Tissue Processing and Staining 
H&E-stained sections of paraffin-embedded bone marrow tissue are typically 
evaluated histologically. However, H&E does not provide always consistent 
hematopoietic cell differentiation. Section thickness is an important factor and 3-
micron sections provide better cellular morphological detail compared to thicker (≥ 
5-micron) sections. Giemsa-stained sections provides better morphological detail 
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compared to H&E-stained sections. For the Giemsa stain, however, acid-decalcified 
tissue results in loss of basophilic-staining structures. The use of chelating-type 
decalcifiers improves Giemsa staining. Plastic embedding provides a significant 
improvement in cellular morphology. Additionally, there is no need for 
decalcification, thus, reducing shrinkage artifact and loss of cellular detail related 
to decalcification methods. Thin sections (≤3 microns) can be easily produced, 
improving cytological quality. However, plastic embedding is time, labor and cost 
intensive and, thus, not justified for a high-throughput operation. Prussian Blue 
stain is used for the assessment of iron stores; acids in decalcifiers or fixatives may 
washout iron stores. Thus, tissue iron could be underestimate [Travlos GS. Et al, 
2006]. 
 
1.3 BONE MARROW FEATURES OF SYSTEMIC INFECTIONS 
For many systemic infections, the bone marrow findings are non-specific but 
compatible with a reactive process. Even when non-specific, the morphological 
evaluation of the bone marrow integrated with clinical history serves to further 
direct workup, including the need for special stains, cultures, serologies, or 
molecular studies.  
Bone marrow changes in infectious and systemic diseases can be studied by 
morphology. Morphologically, similar lesions can arise from different pathological 
agents and one disease can cause several different lesions. Some aetiological agents 
can be detected by tissue sections that have been specially stained, and/or by 
immunohistochemistry. Malignant diseases can be associated with reactive 
changes. Two types of changes that result from the development of an inflammatory 
response or immune disorders can be seen. One lesion is characterized by stromal 
reactions in the connective tissue and microvascular bed, the second by the response 
of haematopoietic stem cells to local or general stimulation [Diebold J. et al, 2000] 
Acute inflammation 
Acute inflammation can be seen in a large number of infections, particularly in 
septicaemia; the manifestations of an acute inflammation can be of different types: 
essudative type; haemorrhagic type; necrotic type; suppurative type. 
In the essudative type, interstitial oedema and small haemorrhages are associated 
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with arteriolo-capillary congestion. The endothelial cells are often hypertrophic. 
Sometimes stellate fibrin deposits are present between the haematopoietic cells. 
Intravascular coagulation may also be seen, particularly in severe infections, and 
this is often associated with haemorrhage or necrosis. Oedema should be 
distinguished from gelatinous transformation of bone marrow. This lesion is 
characterized by hyaline deposits between adipocytes in areas without any 
haematopoietic cells. Gelatinous transformation is observed in patients with severe 
malnutrition and protein loss and in HIV-positive patients [Diebold J. et al, 2000]. 
In the haemorrhagic type, the haemorrhages are often associated with hypoplasia of 
the haematopoietic cells. 
Such alterations have been described in aplasia after hepatitis B infection or in 
patients with severe macrophage (histiocyte) activation syndrome. 
In necrotic type, the ischaemic necrosis during the acute phase of inflammation is 
secondary to arteriolar thrombosis and may be found in patients with septicaemia, 
bacterial endocarditis, different bacterial, viral, fungal or parasitic infections, Q 
fever, dysimmune disorders such as disseminated erythematous lupus, or 
hypersensitivity. The progression of the necrosis is characterized by either a total or 
partial restitution. In some cases, collagenous fibrosis replaces the necrotic areas. 
A particular type of necrosis occurs during the antiphospholipid syndrome and in 
tuberculosis. In acute tuberculosis with haematogenous diffusion, areas of caseous 
necrosis can be observed surrounded by a few histiocytes without epithelioid cells. 
Such caseous necrotic areas are present along the bone trabeculae or in the adipose 
tissue which replaces the haematopoietic cell clusters. Several the acid-resistant 
bacilli are easily observed in these necrotic areas through the use of Ziehl ± Neelsen 
staining. 
The suppurative type lesions are only seen in acute osteomyelitis. During the acute 
phase, typical lesions are characterized by areas of suppurative necrosis containing 
basophilic cellular debris and neutrophils, with a variable number of macrophages. 
 
Chronic inflammation and immune reactions 
Stromal reactions also occur as a result of chronic inflammation. The most frequent 
lesion is characterized by the development of granulomas. However, lymphoid 
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hyperplasia and reactive plasmacytosis are also often observed, mainly because of 
deregulated immune reactions. 
In the granulomatous chronic inflammation, granulomas are identified by an 
accumulation of histiocytes or epithelioid cells organized in a nodular pattern with 
sharp outlines. Giant cells may also be present. The centres of the granulomas may 
be occupied by different types of necroses according to the aetiology; for example, 
fibrinoid in hypersensitivity, caseous in tuberculosis. The granulomas may be 
surrounded by lymphocytes, with a predominance of T-cells over B-cells. 
 
 
Figure 11: Conditions associated with bone marrow granulomas [Brunning RD et al, 
1994]. 
 
In the reactive lymphoid lesions, lymphoid cell hyperplasia has been described in 
numerous different diseases; lesions are more frequently seen in patients older than 
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50 years of age and in women. Thus there is not a clear distinction between 
lymphoid cell hyperplasia as a pathological or a physiological phenomenon. In 
younger patients, such lymphoid hyperplasias seem to be more often associated 
with various chronic inflammatorydiseases or immune disorders. 
Histopathology and immunohistochemistry allow three different types of reactive 
lymphoid lesions to be distinguished: 
-reactive lymphocyte aggregates; 
-lymphoid follicles with germinal centres; 
-reactive lymphohistiocytic infiltrates. 
The most important differential diagnosis is represented by bone marrow 
involvement in malignant lymphomas. Reactive lymphoid aggregates should not be 
confused with early infiltrates of small B- or T-cell ML (B-CLL, 
lymphoplasmacytic ML, splenic marginal zone lymphoma, mantle cell lymphoma, 
T prolymphocytic leukaemia, etc.). 
 
 
Figure 12: Criteria for benign lymphoid lesions and malignant lymphomas 
including Hodgkin's disease [Brunning RD et al, 1994]. 
 
The immunoblastic hyperplasia is a very rare condition, never seen in isolation. In 
viral diseases, particularly in infectious mononucleosis, a small number of 
immunoblasts can be observed associated with reactive lymphoid lesions, mainly 
with reactive lymphohistiocytic infiltrates. They can be of the B-cell and/or T-cell 
type. 
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Plasmacytosis is a plasma cell hyperplasia which is commonly found in patients 
with chronic inflammatory diseases, in dysimmune disorders, in septicaemia, and 
in HIV infection. 
Concerning histiocytic hyperplasia includes different types: histiocytosis with 
haemosiderin, disseminated histiocytosis, histiocytosis with haemophagocytic 
syndrome, histiocytosis with phagocytosis of infectious agents. 
In the chronic inflammation with fibrosis, collagen bands can develop around 
vessels and/or granulomas. Areas of fibrosis can also replace previous necrosis. 
Interstitial oedema with a variable number of plasma and lymphoid cells may be 
associated.  
In chronic diseases with amyloidosis, amyloid deposits may occur in chronic 
inflammations or in dysimmune diseases. The deposits are mainly present on the 
vessel walls or in the interstitium. 
Haematopoietic cell line modifications 
These modifications are probably secondary to the production of various cytokines 
which either block or stimulate the proliferation of haematopoietic stem cells 
(growth factors) and their differentiation. 
In acute inflammation, an increase in the number of cells of the granulocytic series 
is often observed. In some cases, hyperplasia is associated with an accumulation of 
mature neutrophil granulocytes in the centre of the medullary spaces around the 
venous sinuses. In other cases, due to the rapid delivery of mature granulocytes to 
the peripheral blood through the venous sinuses, the majority of the cells of the 
granulocytic series are immature. In very severe infections (septicaemia), an 
absence of mature granulocytes is associated with a proliferation of myelocytes and 
promyelocytes, mimicking the process of acute or chronic leukaemia (leukaemoid 
reaction). An increase in megakaryocytes has been seen during infection, 
particularly in cases of disseminated intravascular coagulation. In different 
inflammatory diseases, anaemia is common and is responsible for an erythroblastic 
hyperplasia. In cases of severe anaemia, the accumulation of large basophilic 
erythroblasts may mimic myelodysplasia. In septicaemia, modifications of the three 
main cell lines can occur and may be responsible for false diagnosis of acute or 
chronic leukaemia or myelodysplasia. In severe infection, hypoplasia or even 
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aplasia can be observed, as well as oedema, haemorrhage, fibrin deposits, necrosis 
or even fibrotic organization.  
In chronic inflammation, stimulation of stem cells leads to hyperplasia of one, two 
or all of the bone marrow haematopoietic normal cell lines. In some cases 
hyperplasia predominates among cells of the granulocytic series, with numerous 
promyelocytes and myelocytes along the bone trabeculae and mature neutrophil 
granulocytes in the centre of the medullary spaces. The number of eosinophil 
granulocytes can also be increased, particularly in cases of drug hypersensitivity, 
allergy, collagen diseases, inflammation due to parasites or Hodgkin and T-cell ML. 
In eosinophilic hyperplasia, macrophages may contain Charcot-Leyden crystals. 
Erythroblastic hyperplasia can be observed during infection with Parvovirus B19. 
Giant erythroblasts and multinucleated erythroblasts are dispersed in the bone 
marrow. Viral inclusions can be seen in the nuclei of erythroblasts. The other cell 
lines are normal. This viral infection of the erythroblasts can cause a severe anaemia 
or an anaplastic crisis. 
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2. EXPERIMENTAL PART 
 
2.1 Aim of the Study 
We sought to investigate a series of bone marrow specimens from forensic autop-
sies, with focus on postmortem morphological changes and utility of the immuno-
phenotypical analysis for medical-legal purposes. 
 
2.2 Material and Methods 
 
Sampling 
Overall, thirty-six (three series) samples of the sternum taken during autopsies were 
examined:  
 
1) 11 samples were taken from subjects who died due to suspected drowning, in the 
period 2015-2017. The samples were placed inside a plastic container and stored in 
the freezer (-20C°) without being subjected to further treatment (case 1-11); 
 
Case 1 (MY) 
Age: 35 years old; 
Date of disappearance: 03.00 p.m of 02.08.2016; 
Date of discovery: 05.30 p.m of 02.08.2016; 
Date of the autopsy examination: 10.00 a.m. of 05.08.2016; 
Cause of death: acute respiratory failure secondary to mechanical asphyxiation 
from drowning in fresh water; 
Toxicological data: BAC 0,17 g/dL. 
 
Case 2 (SJ) 
Age: 7 years old; 
Date of disappearance: 04.00 p.m of 11.05.2016; 
Date of discovery: 01.30 a.m of 12.05.2016; 
Date of the autopsy examination: 11.00 a.m. of 14.05.2016; 
Cause of death: acute respiratory failure secondary to mechanical asphyxiation 
from drowning in fresh water; 
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Toxicological data: negative. 
 
Case 3 (BP) 
Age: 87 years old; 
Date of disappearance: 01.00 p.m of 03.08.2016; 
Date of discovery: 03.30 p.m of 03.08.2016; 
Date of the autopsy examination: 11.00 a.m. of 06.08.2016; 
Cause of death: acute myocardial event with ischemic or arrhythmic origin, in sub-
jects with severe coronary artery disease and fibro-adipose substitution of myocar-
dial tissue; 
Toxicological data: BAC 0,29 g/dL. 
 
Case 4 (BF) 
Date of disappearance: 09.07.2016; 
Date of discovery: 01.00 p.m of 21.10.2016; 
Date of the autopsy examination: 11.00 a.m. of 27.10.2016; 
Tanatological data: advanced state of putrefaction. 
Cause of death: acute respiratory failure secondary to mechanical asphyxiation 
from drowning in fresh water. 
 
Case 5 (TA) 
Age: 34 years old; 
Date of disappearance: 05.00 p.m of 16.04.2017; 
Date of discovery: 24.04.2017; 
Date of the autopsy examination: 11.00 a.m. of 28.04.2017; 
Cause of death: acute respiratory failure secondary to mechanical asphyxiation 
from drowning in fresh water; 
Toxicological data: BAC 0,9 g/dL. 
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Case 6 (BL) 
Age: 52 years old; 
Date of disappearance: 08.11.2017; 
Date of discovery: 02.00 p.m of 09.11.2017; 
Date of the autopsy examination: 11.00 a.m. of 10.11.2017; 
Cause of death: acute respiratory failure secondary to mechanical asphyxiation 
from drowning in fresh water; 
Toxicological data: negative. 
 
Case 7 (RMG) 
Age: 83 years old; 
Date of disappearance: 09.00 a.m of 22.10.2017; 
Date of discovery: 12.00 a.m of 22.10.2017; 
Date of the autopsy examination: 11.00 a.m. of 27.10.2017; 
Cause of death: acute respiratory failure secondary to mechanical asphyxiation 
from drowning in fresh water; 
Toxicological data: negative. 
 
Case 8 (AG) 
Age: 79 years old; 
Date of disappearance/Date of discovery: 10:15 a.m. of 22.06.2016; 
Date of the autopsy examination: 11.00 a.m. of 24.06.2016; 
Cause of death: cardiac death; 
Toxicological data: 408 ng/ml of 7-amino-clonazepam 
 
Case 9 (HCD) 
Age: 48 years old; 
Date of disappearance: 02.03.2015; 
Date of discovery: 04.03.2015; 
Date of the autopsy examination: 06.03.2015; 
Cause of death: acute respiratory failure secondary to mechanical asphyxiation 
from drowning in fresh water; 
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Toxicological data: negative. 
 
Case 10 (KV) 
Age: 31 years old; 
Date of disappearance: 2-5 days prior to the discovery of the body; 
Date of discovery: 24.11.2015; 
Date of the autopsy examination: 11.00 a.m. of 25.11.2015; 
Cause of death: acute respiratory failure secondary to mechanical asphyxiation 
from drowning in fresh water; 
Toxicological data: BAC of 1,47 g/dL. 
 
Case 11 (DN) 
Age: 26 years old; 
Date accident: 30.07.2016; 
Date of death: 04.08.2016 at the hospital; 
Date of the autopsy examination: 11.00 a.m. of 05.08.2016; 
Cause of death: drowning syndrome; 
Toxicological data: negative. 
 
2) 10 samples were taken from subjects who died due to several causes; the samples 
were fixed in formalin for a variable time (case 12-21). 
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3) 15 samples taken from non-forensic autopsies (cases 22-36). 
 
10 patients died for oncological advanced staged carcinomas and 5 for non-onco-
logical causes such as failure of organ-solid transplantations (n. 3 patients) or criti-
cal multi-comorbidities in older ages (1 cases with liver diseases, 2 cases with in-
terstitial pneumopatiae). 
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Histological and Immunohistochemical analysis 
 
Haematoxylin and eosin staining 
H&E staining has been performed on all samples after decalcification&fixation.  
Morphological details has been categorized by three pathologists. Part of single 
sternum has been decalcified and fixed at different time (range in days). 
Decalcifier I is a unique decalcifying solution that has the ability to fix and decalcify 
at the same time. Bone specimens may be completely fixed and decalcified in ap-
proximately 2-4 hours or slow processing time (range in days) in order to preserve 
hemopoietic cells. Tissues decalcified in this solution cut with ease and routine 
H&E techniques produce excellent stained sections. 
 
Immunopanel of antibodies 
Immunohistochemistry has been performed on all cases after inclusion of the fol-
lowing commercially available antibodies: CD20, CD3, CD71, CD61, myeloperox-
idase and CD34 (commercially available clones).  
 
Digital Pathology Interpretation 
Data analysis has been performed by using both the Olympus BX51 microscope 
and D-Sight/Menarini Fluo scan-scope, after digitalization of the glass slides (e-
slide). 
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2.3 RESULTS 
Histopathological and immunophenotypical findings 
Overall, bone marrow samples were morphologically interpretable in 21/36 (58%) 
cases, were fully (after morphological and immunophenotypical data) interpretable 
in 22/36 (61%) cases, respectively 1/11 (9%) in the frozen samples, in 8/10 (80%) 
in the prospective day-by-day slow decalcified series and in 13/15 (87%) non-fo-
rensic series. 
All trilinear haematopoietic cells (myelo-eritroid cells and megacariocytes) were 
detailed at both morphology and immunophenotypical levels in all groups expect 
in the frozen series, where the apoptotic degenerative tissue was observed. 
In the single cases (1/11, 9%) of samples taken at frozen temperature resulted fully 
interpretable; cellularity and immunophenotypical characters such as distinction in 
between myeloid and eritroid components were maintained.  
The rest of the frozen series (9 cases out of 11, 91%) allowed visualization of the 
overall bone marrow cellularity, without distinction of the single components.   
In the prospective day-by-day decalcified series 7/10 (70%) of cases were interpret-
able for histopathology. Cellularity and detailed cellular components (mielo-ery-
troid distinction and megacaryocytes) by using immunohistochemistry were dis-
tincted in 8/10 (80%). Immunophenotypical analysis may be well interpreted on 
tissue after slow decalcification and fixation within a 8-14 range days.  
Frozen samples are not recommended for histopathological evaluation and subse-
quent immunophenotypical analysis, due to diffuse absence of vital tissue. H&E 
staining, due to apoptotic amorphous tissue which do hybridize the proteins with 
false positive results when immunohistochemical analysis was performed. 
CD71 was assessable as dots at frozen samples, without morphological details, and 
be evaluable as percentages of cells. CD71 in non-forensic and prospective cases 
was easily countable. 
CD3, CD20 and CD34 did not show any positivity in the frozen sternum, whereas 
in the remaining series showed immunoexpression according to appropriate specific 
cells (T and B lymphoid and immature cells). 
Myeloperoxidase usually does show aspecific background at frozen samples, 
whereas CD71 may be distincted and be countable as number of cells. 
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Figures (from 13-21) and Table summarized aforementioned results. 
 
  
Table 1. Bone marrow & sternum: sum up of 36 cases studied and interpretable immunoexpression
Case Myloperoxidase CD71 CD61 CD34
number
frozen stored setting
1 evaluable tissue evaluable evaluable evaluable evaluable
2 not evaluable false positive absence of expression absence of expression false positive
3 not evaluable false positive absence of expression absence of expression false positive
4 not evaluable false positive absence of expression absence of expression false positive
5 not evaluable false positive absence of expression absence of expression false positive
6 not evaluable false positive absence of expression absence of expression false positive
7 not evaluable false positive absence of expression absence of expression false positive
8 not evaluable false positive absence of expression absence of expression false positive
9 not evaluable false positive absence of expression absence of expression false positive
10 not evaluable false positive absence of expression absence of expression false positive
11 not evaluable false positive absence of expression absence of expression false positive
prospective 
decalcified & fixed
day-by-day  setting
12 evaluable tissue evaluable evaluable evaluable evaluable
13 evaluable tissue evaluable evaluable evaluable evaluable
14 evaluable tissue evaluable evaluable evaluable evaluable
15 evaluable tissue evaluable evaluable evaluable evaluable
16 evaluable tissue evaluable evaluable evaluable evaluable
17 evaluable tissue evaluable evaluable evaluable evaluable
18 evaluable tissue evaluable evaluable evaluable evaluable
19 not evaluable evaluable evaluable evaluable evaluable
20 not evaluable not evaluable not evaluable not evaluable not evaluable
21 not evaluable not evaluable not evaluable not evaluable not evaluable
non-forensic setting 
22 evaluable tissue evaluable evaluable evaluable evaluable
23 evaluable tissue evaluable evaluable evaluable evaluable
24 evaluable tissue evaluable evaluable evaluable evaluable
25 evaluable tissue evaluable evaluable evaluable evaluable
26 evaluable tissue evaluable evaluable evaluable evaluable
27 evaluable tissue evaluable evaluable evaluable evaluable
28 evaluable tissue evaluable evaluable evaluable evaluable
29 evaluable tissue evaluable evaluable evaluable evaluable
30 not evaluable not evaluable not evaluable not evaluable not evaluable
31 not evaluable not evaluable not evaluable not evaluable not evaluable
32 evaluable tissue evaluable evaluable evaluable evaluable
33 evaluable tissue evaluable evaluable evaluable evaluable
34 evaluable tissue evaluable evaluable evaluable evaluable
35 evaluable tissue evaluable tissue evaluable tissue evaluable tissue evaluable tissue
36 evaluable tissue evaluable tissue evaluable tissue evaluable tissue evaluable tissue
35 
 
Figure from 13 to 22 
 
 
 
Figure 13: H&E bone marrow (decalcification and fixation, 10 days) (day-by-day slow 
decalcification) 
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Figure 14. H&E bone marrow with day-by-day decalcification without appropriate fixa-
tion 
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Figure 15. H&E staining bone marrow with apoptotic phenomena (day-by-day decalcifi-
cation and fixation, 4 days) 
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Figure 16. H&E bone marrow with day-by-day decalcification process (9 days). 
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Figure 17. H&E with appropriate decalcification but absence of appropriate fixation (6 
days) 
  
40 
 
 
 
Figure 18. Myeloperoxidase (MPX) expression in bone marrow (decalcification and fixa-
tion, 14 x) (10 days). 
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Figure 19. Myeloperoxidase (MPX) in bone marrow with background (false evaluation 
of positive immunoexpression) 
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Figure 20. CD71 magnification 11x. Cellular specific elements are easily evaluable 
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Figure 21. Frozen bone marrow: absence of immunoexpression (lack of tissue available) 
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2.4 Discussion 
The present study showed that: 
1) slow day-by-day decalcification process usually let the bone marrow from ster-
num after forensic autopsies, be morphologically interpretable;  
2) immunophenotypical analysis may be performed on tissue after slow decalcifi-
cation and fixation usually within 8-14 days as appropriate range of sensibility; 
3) frozen samples from sternum are not recommended for bone marrow histopatho-
logical evaluation. 
At routine level, the introduction of fast diagnostic tracks in many areas (i.e of on-
cology), the traditional processing of bone marrow biopsies (BM), requiring either 
resin embedding or lengthy fixation and decalcification, is due to an upgrade. 
Thanks to a growing number of new commercially available tissue processors, mi-
crowave-enhanced processing is becoming a standard tool in the pathology labora-
tory, allowing rapid fixation and decalcification of BM with preserved morphology 
and antigens. The use of a commercially available EDTA-based decalcification 
fluid in combination with the LOGOS J, a closed microwave-enhanced tissue pro-
cessor, for overnight fixation, decalcification, and paraffin impregnation of the BM. 
This allows next-day reporting without impaired morphology or immunohisto-
chemistry, and even improved DNA quality of the BM. The aim of our study was 
not to reduce time of reporting, differently was to manage sternum and preservation 
of bone marrow to obtain sensitive and specific information at morphology.  
Systematic investigation of bone marrow samples (BM) in case of forensic autop-
sies is not yet a routine procedure; most of the studies published in this field have 
described the use of BM as an alternative tissue in toxicology analyses to analyse 
changes after the abuse of drugs or alcohol, and in cases when blood samples are 
unavailable such as skeletonized, bloodless or putrefied cadavers. BM is also used 
in forensic genetic analysis and in diagnosis of drowning using the diatom test. In 
the forensic literature there are not many studies that deal with the systematic anal-
ysis of the bone marrow to establish a cause of death. [Roll P. at al, 2009; Hellerich 
U. et al, 1992; De Lima M.A. et al, 2004; Tattoli L. et al, 2014]. Single case reports 
45 
 
are also reported describing a sudden death due to acute and chronic leukemia un-
known during life [Umezawa A. et al, 1990; Saka K et al, 2007]. 
From a review of the literature there are only two studies that focus on the 
importance of the systemic study of bone marrow as useful tool for obtaining the 
cause of death.  
In the study conducted by Roll et al and published in 2009, out of 5740 forensic 
autopsies in 225 cases (3.92%) a bone marrow sample was taken. The sampling was 
carried out when an enlarged spleen was found at the sectarian examination, when 
bleeding disorders were visible, in case of suspected poisoning, in case of suspected 
septicaemia or when the cause of death was not clear. Bone marrow samples were 
taken from 12 hours to 140 hours post-mortem from the anterior iliac crests, and 
were immediately fixed in a 10% formalin solution neutral buffer. In collaboration 
with the Institute of Pathology, Medical University of Graz, the fixed specimens 
were further elaborated. These probes were stored in 10% buffered formalin 
solution for about 24 hours. Subsequently, 5-8 mm cross sections were cut with a 
special one water-cooled saw and repaired again in buffered formalin for a further 
24 hours. Then the tissue samples were incorporated, decalcified, paraffined 
embedded, cut to 5-6 micron and stained routinely with H & E, Giemsa, silver 
reticulina stain and blue of Prussia. In selected cases, when there was a suspected 
neoplasm, immunohistochemical analyzes were performed with antibodies to CD3, 
CD5, CD20, CD23, light chains (kappa elambda), heavy chains (IgA, IgG, IgM and 
IgD), myeloperoxidase, CD15, CD33, CD34, CD68. Of 225 investigated BM 
biopsies they are were able to detect 40 cases with neoplastic disorders not known 
prior to death. All these BM probes were representative for diagnosis and showed, 
despite the fact that the BM specimens were extracted up to 140 h post-mortem, 
surprisingly few autolytic changes when the sections were compared to those of 
other organs from the same corpse. This good state of BM preservation, due to good 
conservation of corpses and optimal processing of BM specimens, allowed besides 
routine and special stains even immunohistochemical investigations with various 
sensible antibodies.  
All cases diagnosed as myelodysplasias showed in addition to dysplasias and 
atypias within all haematopoietic cell lines marked increase of iron deposits, typical 
46 
 
for these diseases [Frisch B. et al, 1985; Cortelezzi A et al, 2000, Orazi A. et al, 
2007]. Within the group of non-neoplastic BM changes the majority showed signs 
consistent with septicaemia or intoxications [Roll P. et al, 2009] confirming the 
findings during forensic autopsy. The only histopathologically relevant organ 
providing a correct diagnosis of postpartum thrombotic thrombocytopenic purpura 
showing hyaline thrombi in small vessels was the BM [Budde U. et al, 2004]. The 
authors concluded that it seems necessary to investigate the BM histopathologically 
if: the forensic pathologist cannot detect ‘‘real’’ cause of death during autopsy, 
pathological blood count is known or an enlarged spleen is found, septicaemia is 
established or suspected, fever of unknown origin is reported, suspected or proofed 
intoxications are documented, and there were symptoms of haemorrhagic diathesis 
or bleeding tendencies, such as extensive petechias, gastrointestinal or cerebral 
bleedings or missing or vague livores (signs suspicious for a bleeding disorder). 
Another study conducted by Tattoli et al, reported that hematopoietic tissue is 
sensitive to external influences, such as dietary restriction, malnutrition, chronic 
inflammation, toxicity, and proliferative or neoplastic disorders. Cell differentiation 
also occurs as a result of several stimuli such as infections or other systemic 
diseases. In their study Tattoli et al. collected a BM samples from cases (n = 73) of 
medicolegal autopsy performed at the Department of Legal Medicine in Bari (Italy) 
and at the Institute of Legal Medicine and Forensic Sciences in Berlin (Germany). 
BM was sampled from the first part of the sternum, in the mid-portion, by both 
needle aspiration and biopsy. BM aspirated (2 -5 ml) was collected in a 10 ml 
syringe connected to a BM needle by piercing the sternum. Approximately 0.25 to 
0.5 ml of aspirate were smeared on slides without the use of anticoagulant. Once 
dried, they were stained with the May-Grunwald-Giemsa and then examined 
(preferably using an immersion oil, 100 lens in a light microscope). Biopsies from 
BM trephins were performed on same sternum portion with biopsy needle. In 
collaboration with the Department of Pathology, samples were fixed in 4% buffered 
formalin solution for approximately 24 hours. Subsequently, the samples were 
decalcified, included in paraffin, cut into 5 mm slices and stained with hematoxylin 
and eosin ( &E). In selected cases immunohistochemical analyzes were performed. 
The authors found changes in the composition of the MB in relation to the age of 
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the subject. There was a progressive loss (after 30 years) of hematopoietic tissue 
and a corresponding increase in the amount of adipose tissue. They showed that the 
anatomical structure of BM samples showed less autolytic changes than those in 
other organs. In BM aspirates tissue autolysis was also related to the increasing 
post-mortem interval (PMI): nuclei gradually shrank and darkened and the cells 
tended to coalesce; vacuolar degeneration of the cell cytoplasm, which became 
eosinophilic, the granulocytic cells underwent necrotic modifications of their 
granules. The authors found changes related to neoplastic diseases and alterations 
not related to neoplastic diseases; for example in cases where the subjects died of 
sepsis the BM simples showed a prevalence of neutrophils and their precursors. In 
fact, there was an increased cellularity with a large number of myeloid precursors, 
sometimes with a small aggregate of mature neutrophils. Some cases of viral 
infections showed a reduced neutrophil maturation with a predominance of 
immature cells, while the modifications mainly correlated with alcohol abuse were 
hypoplasia, with a lower degree of maturation and, typically, the absence of cells 
near the trabeculae. 
In four cases, BM cell modifications could be indicative of anaphylactic reactions. 
In 28 cases used as controls, no changes in BM cellular morphology were observed 
in either the aspirates or the biopsies. The authors concluded that the sternum may 
offer the ideal matrix from which to obtain morphological evidence of what actually 
happens in bone marrow. The sternum has the advantage of being more readily 
accessible during autopsy, as compared to other sites like the iliac crest, femur, ribs, 
vertebral bodies. These results suggest that BM investigation could provide 
additional reliable information about the duration of the inflammatory process, 
reflecting the patient’s ability to respond to external stimuli. The degree of 
proliferation and differentiation of particular lineages of haematopoietic stem cells 
is known to be secondary to the production of cytokines which either block or 
stimulate the BM cells, as a result of infections or other systemic diseases which 
can be studied by cell morphology analysis. In fact, the recent literature has 
underlined the role of post-mortem chemical and immunological mediators in 
determining the manner of death, especially when morphological signs of disease 
are lacking [Santangelo S. eta al, 2001; Solarino B et al, 2009]. 
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Furthermore, in literature there is considerable evidence that the BM plays a key 
role in allergic inflammation by inducing an increased production of inflammatory 
cell progenitors particularly in cases of drug hypersensitivity or allergy [Wood LJ. 
et al, 2002; Dinger MR et al, 2007].  
In this frame, our study showed interesting data that let the BM be play a 
role in at least a subset of forensic purposes. 
The single comprehensive systematic study concerning BM histology from forensic 
autopsies reported 30 cases with BM changes after chronic alcohol consumption 
(Roll et al.). In a smaller study, BM findings of 5 necropsied cases of drug addicts 
revealed titanium pigment within body tissues including the BM. Single case re-
ports on acute and chronic leukaemias undiagnosed during lifetime but detected by 
postmortem. Roll et al. documented and worked up demonstrating the importance 
of histopathological BM investigations in various conditions. Of 225 investigated 
BM biopsies they were able to detect 40 cases with neoplastic disorders not known 
prior to death. All these BM probes were representative for diagnosis and showed, 
despite the fact that the BM specimens were extracted up to 140 h post-mortem, 
surprisingly few autolytic changes when the sections were compared to those of 
other organs from the same corpse. We are in agreement with findings from Roll et 
al. due to the fact that our data showed a good state of BM preservation, due to good 
conservation of corpses and optimal processing of BM specimens in the prospective 
studies. In the manuscript by Roll et al. the post-mortem discovered neoplasia 
turned out to be of great importance for the responsible clinicians with regard to 
liabilities for medical malpractices.  
Tattoli et al. collected sternum due to the limit of poor samples obtainable by iliac 
aspiration, especially in post-mortem work-up. In the sternum, BM remains haemo-
poietically active until late in life, and shows an increase activity more readily than 
many other bones during regeneration. The sternum may offer the ideal matrix from 
which to obtain morphological evidence of what actually happens in bone marrow, 
avoiding the risks both of hypocellularity and of post-mortem involution. Moreover, 
the sternum has the advantage of being more readily accessible during autopsy, as 
compared to other sites like the iliac crest, femur, ribs, vertebral bodies. With this 
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technique, the specimen quality is a remarkable aspect, because a diagnostic inter-
pretation is possible only if morphologically detectable cells are available. In all the 
specimens evaluated, Tattoli et al reported that the age-related changes of BM were 
evident, as reported in the pertinent literature. It was possible to analyse all the 
probes, even if BM samples were taken up to 198 h after death; the BM anatomical 
structure was still detectable in a cadaver at 32 days after death. As compared with 
other organs, the integrity of BM despite putrefaction phenomena was evident in 
histological sections, and the lineage precursors were quite recognizable even at an 
increasing PMI. In our study we obtained the best immunophenotypical analysis 
after slow decalcification and fixation usually within 8-14 days in comparison with 
data from Tattoli et al. Decalcifier I is a unique decalcifying solution that has the 
ability to fix and decalcify at the same time. Needle biopsies may be completely 
fixed and decalcified in one hour or less, moreover small bone specimens and cal-
cified arteries may be completely fixed and decalcified in approximately 2-4 hours. 
Tissues decalcified in this solution cut with ease and routine H&E techniques pro-
duce excellent stained sections. The Surgipath Decalcifier I-II combination can save 
valuable time and more importantly, valuable specimens. Boehm et al. describe 
bone marrow (BM) biopsies, tartrate-resistant acid phosphatase (TRAP) staining as 
the gold standard for the characterisation of osteoclasts. TRAP is one of the few 
enzymes that is histochemically detectable on formalin-fixed paraffin-embedded 
tissue. The study investigated whether TRAP was also able to visualise BM osteo-
clasts in autopsy tissue. It was hypothesised that, due to a progressive loss of enzy-
matic activity in osteoclasts post-mortem, TRAP staining could allow the time of 
death of a patient to be determined. This study showed that BM osteoclasts stay 
TRAP-positive for 7 days post-mortem, although with markedly reduced TRAP-
SIs compared with biopsies. Since TRAP-SIs were not correlated with the duration 
of PMI, TRAP staining of BM osteoclasts cannot serve as a tool to determine the 
time of death of a patient. In our study we did not correlate findings with time of 
death. The same Authors studied the α-Naphthyl acetate esterase (ANAE), enzymes 
that are histochemically detectable on formalin-fixed paraffin-embedded tissue. In 
bone marrow (BM) biopsies, ANAE staining highlights megakaryocytes. Authors 
investigated autopsy BM to determine whether ANAE staining intensity (SI) was 
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associated with postmortem intervals (PMI, period between death and autopsy), and 
thus could allow the time of death of a patient to be deduced. Again, these molecules 
has not been evacuate in our series. They finally reported that ANAE-SIs in post-
mortem BM samples were independent of PMI. Thus, ANAE staining of BM 
megakaryocytes cannot serve as an indicator for time-since-death of a patient. Wie-
techa-Posluszny et al. applied a new instrumental approach to the analysis of human 
bone marrow for forensic purposes. A new screening method for the detection of 
more than 30 psychoactive drugs in bone marrow was developed and applied to 
case samples. They finally presented a method that could potentially find an appli-
cation in forensic analysis. We can not compare our findings with aforementioned, 
our series did not involve drug abusers.  
2.5 Conclusions 
We concluded that day-by-day (slow) decalcification process usually let the bone 
marrow from sternum after forensic autopsies, be morphologically interpretable. 
Moreover, immunophenotypical analysis such as myeloperoxidase, CD71, CD61 
and CD34 may be performed on tissue after slow decalcification and fixation usu-
ally within 8-14 days with interpretable assessment. Finally, we do not recommend 
frozen samples for histopathological evaluation in bone marrow.  
The above reported considerations lead to the following final conclusion. The 
sternum collection in forensic autopsies in order to evaluate the bone marrow is not 
mandatory in all the forensics cases. However it is recommended in all the cases of 
suspected haematological diseases, sudden deaths and septic deaths. In these cases 
the forensic pathologist aims to collect a section of the sternum 2x3 cm, which must 
be subjected to slow decalcification and fixation within 8-14 days. Following this 
procedure it is possible to obtain interpretable bone marrow preparations suitable 
also for the immunophenotypical analysis. 
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